WEB FOCUS
Top of page
2008
Leukemia Proceedings on Myeloproliferative Neoplasms
This spotlight elegantly and masterly covers all the most up-to-date steps in BCR-ABL-negative Myeloproliferative Neoplasms and opens the door to a detailed molecular understanding of the multi-step nature of blood cancers. The topic is covered from several perspectives including history, disease classification, genetics, signaling, drug development, treatment options, and MPN stem cell biology.
This freely available spotlight series is sponsored by Merck & Co, Inc, TargeGen, Inc., and Celegene Corporation.
